title: [Report of 3162 cases of holmium laser enucleation of the prostate and review].
abstract: OBJECTIVE
  To evaluate the safety, effectiveness, and outcomes of holmium laser enucleation of the prostate (HoLEP) for patients with symptomatic enlarged prostate after 11 years of experience.
  
  
  METHODS
  The 3162 evaluable patients treated with holmium laser enucleation of the prostate at our institution between August 2001 and August 2011 were retrospectively analyzed. Study variables included International Prostate Symptom Score, quality of life, maximum urinary flow rate, and incidence of complications.
  
  
  RESULTS
  HoLEP were performed successfully completed, not patients which occurs as electric cutting syndrome. The operation time was (60.8 ± 18.4) minutes; average resection of prostate quality was (45.4 ± 24.4) g. The hemoglobin reduce though surgery was (1.81 ± 0.93) g/L; percentage of red blood cell change was 1.24% ± 0.43%, and sodium blood drop was (1.14 ± 0.35) mmol/L. Postoperative patients of hospital stay (3.1 ± 1.1) days, average time of indwelling catheter time was (2.3 ± 0.8) days. Patients were followed up for 6-131 months time, an average of 32.4 months. Postoperative patients with international prostate symptom score progressive declined. The quality of life score was 2.2 ± 1.7, and it less than preoperative (5.7 ± 3.3, t = 2.447, P < 0.01). The time of follow-up droped further, and postoperative comparative differences have statistical significance (t = 2.179, 2.228, 2.306 and 2.365, P < 0.05). The maximum urinary flow rate also improved (P < 0.05). Postoperative complications included bladder neck contracture (4 cases), urinary tract infection (107 cases), urethral stricture (11 cases) and urinary incontinence (11 cases). The 11 patients reoperation.
  
  
  CONCLUSIONS
  HoLEP treatment of benign prostatic hyperplasia could achieve the advantages of open surgery the same effect. It had fewer damage, faster recovery, fewer complications, and is a good treatment option.
authors.affiliation: Department of Urology, Kunming General Hospital of Chengdu Military Command, Kunming 650032, China.
authors.forename: Qi-gui
authors.initials: QG
authors.lastname: Liu
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.forename: Wei-qing
authors.initials: WQ
authors.lastname: Ma
authors.forename: Li-xin
authors.initials: LX
authors.lastname: Kuang
authors.forename: Wen-tao
authors.initials: WT
authors.lastname: Zhang
authors.forename: Kun
authors.initials: K
authors.lastname: Dou
authors.forename: Jian-zhong
authors.initials: JZ
authors.lastname: Yao
authors.forename: Wei
authors.initials: W
authors.lastname: Cao
authors.forename: Qing-yu
authors.initials: QY
authors.lastname: Zhou
authors.forename: Yue-li
authors.initials: YL
authors.lastname: Wang
authors.forename: Juan
authors.initials: J
authors.lastname: Duan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D053844:Lasers, Solid-State; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000601:surgery*; D012189:Retrospective Studies; D020728:Transurethral Resection of Prostate; D016896:Treatment Outcome